Cargando…

Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus

SIMPLE SUMMARY: Avian hepatitis E has been widespread in many countries in the last few years and has caused immense economic losses to the poultry industry worldwide. There are still no commercial avian hepatitis E virus (HEV) vaccines so far. ORF3 protein subunit vaccines for HEV strain in laying...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Hongjian, Chi, Zengna, Zhao, Hui, Zhang, Yawen, Zhang, Yuduo, Wang, Yixin, Chang, Shuang, Zhao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784926/
https://www.ncbi.nlm.nih.gov/pubmed/36548837
http://dx.doi.org/10.3390/vetsci9120676
_version_ 1784857928351612928
author Yan, Hongjian
Chi, Zengna
Zhao, Hui
Zhang, Yawen
Zhang, Yuduo
Wang, Yixin
Chang, Shuang
Zhao, Peng
author_facet Yan, Hongjian
Chi, Zengna
Zhao, Hui
Zhang, Yawen
Zhang, Yuduo
Wang, Yixin
Chang, Shuang
Zhao, Peng
author_sort Yan, Hongjian
collection PubMed
description SIMPLE SUMMARY: Avian hepatitis E has been widespread in many countries in the last few years and has caused immense economic losses to the poultry industry worldwide. There are still no commercial avian hepatitis E virus (HEV) vaccines so far. ORF3 protein subunit vaccines for HEV strain in laying hens and broilers were prepared, respectively, in this study; and the challenge protection test confirmed that the vaccine could reduce the viral shedding in feces after HEV infection; it provides necessary technical reserve for the prevention and control of avian HEV under existing conditions. ABSTRACT: Avian hepatitis E virus (HEV) is the main etiologic pathogen of chicken big liver and spleen disease which is widely prevalent in China in recent years. However, due to the lack of a highly effective culture system in vitro, a genetically engineered subunit vaccine is the main direction of vaccine development. In this study, ORF3 genes of VaHEV strain from laying hens and YT-aHEV strain from broilers were amplified, respectively, and ORF3 protein was successfully expressed by Escherichia coli prokaryotic expression system. The serum samples were collected periodically to detect avian HEV antibodies by indirect immunofluorescence after specific pathogen free chickens immunized with the two proteins and their mixed proteins, the results showed that all serum samples were positive for antibodies to avian HEV. The antibody-positive chickens were artificially challenged with the cell-adapted strain YT-aHEV strain. The chickens from the immunized control group were infected successfully; no fecal detoxification was detected in the immunized group. In this study, two representative strains of ORF3 subunit vaccines of laying hens and broilers were prepared by prokaryotic expression, the immune effects of different proteins of these were evaluated through immunization and challenge studies in vivo, which provided a new technical possibility for prevention and control of avian HEV.
format Online
Article
Text
id pubmed-9784926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97849262022-12-24 Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus Yan, Hongjian Chi, Zengna Zhao, Hui Zhang, Yawen Zhang, Yuduo Wang, Yixin Chang, Shuang Zhao, Peng Vet Sci Article SIMPLE SUMMARY: Avian hepatitis E has been widespread in many countries in the last few years and has caused immense economic losses to the poultry industry worldwide. There are still no commercial avian hepatitis E virus (HEV) vaccines so far. ORF3 protein subunit vaccines for HEV strain in laying hens and broilers were prepared, respectively, in this study; and the challenge protection test confirmed that the vaccine could reduce the viral shedding in feces after HEV infection; it provides necessary technical reserve for the prevention and control of avian HEV under existing conditions. ABSTRACT: Avian hepatitis E virus (HEV) is the main etiologic pathogen of chicken big liver and spleen disease which is widely prevalent in China in recent years. However, due to the lack of a highly effective culture system in vitro, a genetically engineered subunit vaccine is the main direction of vaccine development. In this study, ORF3 genes of VaHEV strain from laying hens and YT-aHEV strain from broilers were amplified, respectively, and ORF3 protein was successfully expressed by Escherichia coli prokaryotic expression system. The serum samples were collected periodically to detect avian HEV antibodies by indirect immunofluorescence after specific pathogen free chickens immunized with the two proteins and their mixed proteins, the results showed that all serum samples were positive for antibodies to avian HEV. The antibody-positive chickens were artificially challenged with the cell-adapted strain YT-aHEV strain. The chickens from the immunized control group were infected successfully; no fecal detoxification was detected in the immunized group. In this study, two representative strains of ORF3 subunit vaccines of laying hens and broilers were prepared by prokaryotic expression, the immune effects of different proteins of these were evaluated through immunization and challenge studies in vivo, which provided a new technical possibility for prevention and control of avian HEV. MDPI 2022-12-05 /pmc/articles/PMC9784926/ /pubmed/36548837 http://dx.doi.org/10.3390/vetsci9120676 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yan, Hongjian
Chi, Zengna
Zhao, Hui
Zhang, Yawen
Zhang, Yuduo
Wang, Yixin
Chang, Shuang
Zhao, Peng
Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus
title Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus
title_full Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus
title_fullStr Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus
title_full_unstemmed Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus
title_short Application of ORF3 Subunit Vaccine for Avian Hepatitis E Virus
title_sort application of orf3 subunit vaccine for avian hepatitis e virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784926/
https://www.ncbi.nlm.nih.gov/pubmed/36548837
http://dx.doi.org/10.3390/vetsci9120676
work_keys_str_mv AT yanhongjian applicationoforf3subunitvaccineforavianhepatitisevirus
AT chizengna applicationoforf3subunitvaccineforavianhepatitisevirus
AT zhaohui applicationoforf3subunitvaccineforavianhepatitisevirus
AT zhangyawen applicationoforf3subunitvaccineforavianhepatitisevirus
AT zhangyuduo applicationoforf3subunitvaccineforavianhepatitisevirus
AT wangyixin applicationoforf3subunitvaccineforavianhepatitisevirus
AT changshuang applicationoforf3subunitvaccineforavianhepatitisevirus
AT zhaopeng applicationoforf3subunitvaccineforavianhepatitisevirus